WGU D116 Advanced Pharmacology Study Guide:
Practice Questions & Rationale Frameworks
This comprehensive study resource features targeted practice assessments and
detailed rationale breakdowns designed specifically for Western Governors University’s
advanced pharmacology curriculum. It emphasizes complex pharmacokinetic profiles,
advanced pharmacodynamics, and individualized prescriptive authority reasoning
across diverse patient lifespans. Nursing students will build the diagnostic confidence
required to successfully master the objective assessment and safely prescribe in
advanced practice settings.
SECTION 1: PHARMACOKINETICS & PHARMACODYNAMICS
Question 1
Which of the following best describes pharmacokinetics?
A. The study of drug effects on the body
B. The study of drug absorption, distribution, metabolism, and excretion (ADME)
C. The study of drug toxicity
D. The study of drug interactions
Rationale: Pharmacokinetics is "what the body does to the drug" and encompasses the
four processes of Absorption, Distribution, Metabolism, and Excretion (ADME).
Pharmacodynamics, in contrast, is "what the drug does to the body".
,Question 2
The "first-pass effect" refers to:
A. Rapid intravenous administration
B. Drug metabolism in the liver before reaching systemic circulation
C. Drug excretion by the kidneys
D. Drug binding to plasma proteins
Rationale: The first-pass effect occurs when a drug is metabolized in the liver before
reaching systemic circulation, which reduces the bioavailability of orally administered
drugs. Drugs like nitroglycerin and morphine require higher oral doses or alternative
routes to bypass this effect.
Question 3
Bioavailability is defined as:
A. The speed of drug absorption
B. The fraction of an administered dose that reaches systemic circulation
unchanged
C. The volume of distribution
D. The half-life of the drug
Rationale: Bioavailability measures how much of an administered dose reaches the
bloodstream unchanged. Intravenous (IV) administration has 100% bioavailability because
it bypasses absorption and first-pass metabolism.
,Question 4
Which route of administration has the highest bioavailability and fastest onset of action?
A. Oral
B. Subcutaneous
C. Intravenous (IV)
D. Intramuscular (IM)
Rationale: IV administration bypasses absorption barriers and first-pass metabolism,
delivering 100% of the dose directly into systemic circulation. It also provides the most
rapid onset of action.
Question 5
Which pharmacokinetic phase involves reversible movement of medication from the
bloodstream into tissues?
A. Absorption
B. Distribution
C. Biotransformation
D. Elimination
Rationale: Distribution describes the movement of drug molecules between the
bloodstream and body tissues after absorption.
, Question 6
A highly protein-bound medication is administered to a patient with severe
hypoalbuminemia. What effect is most likely?
A. Complete failure of drug absorption
B. Decreased renal filtration of all drug molecules
C. An increased proportion of pharmacologically active unbound drug
D. Elimination of hepatic metabolism
Rationale: Only unbound drug is generally able to cross membranes and interact with
receptors. Reduced albumin can therefore increase free concentrations of highly protein-
bound medications.
Question 7
Which organ is primarily responsible for metabolism of many medications through
cytochrome P450 enzymes?
A. Lung
B. Spleen
C. Liver
D. Pancreas
Rationale: The liver is the major site of drug biotransformation and contains many CYP450
enzymes involved in phase I metabolism.
Question 8
Practice Questions & Rationale Frameworks
This comprehensive study resource features targeted practice assessments and
detailed rationale breakdowns designed specifically for Western Governors University’s
advanced pharmacology curriculum. It emphasizes complex pharmacokinetic profiles,
advanced pharmacodynamics, and individualized prescriptive authority reasoning
across diverse patient lifespans. Nursing students will build the diagnostic confidence
required to successfully master the objective assessment and safely prescribe in
advanced practice settings.
SECTION 1: PHARMACOKINETICS & PHARMACODYNAMICS
Question 1
Which of the following best describes pharmacokinetics?
A. The study of drug effects on the body
B. The study of drug absorption, distribution, metabolism, and excretion (ADME)
C. The study of drug toxicity
D. The study of drug interactions
Rationale: Pharmacokinetics is "what the body does to the drug" and encompasses the
four processes of Absorption, Distribution, Metabolism, and Excretion (ADME).
Pharmacodynamics, in contrast, is "what the drug does to the body".
,Question 2
The "first-pass effect" refers to:
A. Rapid intravenous administration
B. Drug metabolism in the liver before reaching systemic circulation
C. Drug excretion by the kidneys
D. Drug binding to plasma proteins
Rationale: The first-pass effect occurs when a drug is metabolized in the liver before
reaching systemic circulation, which reduces the bioavailability of orally administered
drugs. Drugs like nitroglycerin and morphine require higher oral doses or alternative
routes to bypass this effect.
Question 3
Bioavailability is defined as:
A. The speed of drug absorption
B. The fraction of an administered dose that reaches systemic circulation
unchanged
C. The volume of distribution
D. The half-life of the drug
Rationale: Bioavailability measures how much of an administered dose reaches the
bloodstream unchanged. Intravenous (IV) administration has 100% bioavailability because
it bypasses absorption and first-pass metabolism.
,Question 4
Which route of administration has the highest bioavailability and fastest onset of action?
A. Oral
B. Subcutaneous
C. Intravenous (IV)
D. Intramuscular (IM)
Rationale: IV administration bypasses absorption barriers and first-pass metabolism,
delivering 100% of the dose directly into systemic circulation. It also provides the most
rapid onset of action.
Question 5
Which pharmacokinetic phase involves reversible movement of medication from the
bloodstream into tissues?
A. Absorption
B. Distribution
C. Biotransformation
D. Elimination
Rationale: Distribution describes the movement of drug molecules between the
bloodstream and body tissues after absorption.
, Question 6
A highly protein-bound medication is administered to a patient with severe
hypoalbuminemia. What effect is most likely?
A. Complete failure of drug absorption
B. Decreased renal filtration of all drug molecules
C. An increased proportion of pharmacologically active unbound drug
D. Elimination of hepatic metabolism
Rationale: Only unbound drug is generally able to cross membranes and interact with
receptors. Reduced albumin can therefore increase free concentrations of highly protein-
bound medications.
Question 7
Which organ is primarily responsible for metabolism of many medications through
cytochrome P450 enzymes?
A. Lung
B. Spleen
C. Liver
D. Pancreas
Rationale: The liver is the major site of drug biotransformation and contains many CYP450
enzymes involved in phase I metabolism.
Question 8
